New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator…
Read More »immunogenicity
New Delhi: A new weapon against the debilitating infection of Chikungunya could soon be in the offing. A multi-country Phase…
Read More »